Mimedx Group Stock Analysis

MiMedx Stock Analysis Notes

About 72.0% of the company shares are owned by institutional investors. The book value of MiMedx was now reported as 1.61. The company has Price/Earnings To Growth (PEG) ratio of 2.97. MiMedx Group had not issued any dividends in recent years. The entity had 3235:10000 split on the 2nd of April 2008. MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. Mimedx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 811 people. To find out more about MiMedx Group contact Joseph Capper at 770 651 9100 or learn more at https://www.mimedx.com.

MiMedx Group Investment Alerts

MiMedx Largest EPS Surprises

View All Earnings Estimates

MiMedx Environmental, Social, and Governance (ESG) Scores

MiMedx Stock Institutional Investors

Note, although MiMedx's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MiMedx Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 771.61 M.

MiMedx Profitablity

The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2.

Management Efficiency

MiMedx Group has return on total asset (ROA) of 0.1198 % which means that it generated a profit of $0.1198 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1944 %, meaning that it created $0.1944 on every $100 dollars invested by stockholders. MiMedx's management efficiency ratios could be used to measure how well MiMedx manages its routine affairs as well as how well it operates its assets and liabilities. The MiMedx's current Return On Tangible Assets is estimated to increase to 0.17. The MiMedx's current Return On Capital Employed is estimated to increase to 0.25. At this time, MiMedx's Total Current Assets are most likely to increase significantly in the upcoming years. The MiMedx's current Return On Tangible Assets is estimated to increase to 0.17, while Other Current Assets are projected to decrease to roughly 6.1 M.

Technical Drivers

As of the 13th of February 2026, MiMedx secures the risk adjusted performance of (0.20), and Mean Deviation of 1.76. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MiMedx Group, as well as the relationship between them. Please verify MiMedx Group information ratio and skewness to decide if MiMedx Group is priced some-what accurately, providing market reflects its recent price of 5.09 per share. Given that MiMedx Group has information ratio of (0.29), we recommend you to check MiMedx's last-minute market performance to make sure the company can sustain itself at a future point.

MiMedx Group Price Movement Analysis

MiMedx Group Insider Trading Activities

MiMedx Outstanding Bonds

MiMedx Predictive Daily Indicators

MiMedx Corporate Filings

MiMedx Forecast Models

MiMedx's time-series forecasting models are one of many MiMedx's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MiMedx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

MiMedx Bond Ratings

MiMedx Group financial ratings play a critical role in determining how much MiMedx have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for MiMedx's borrowing costs.

MiMedx Group Debt to Cash Allocation

MiMedx Group currently holds 24.84 M in liabilities with Debt to Equity (D/E) ratio of 0.69, which is about average as compared to similar companies. MiMedx Group has a current ratio of 3.46, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about MiMedx's use of debt, we should always consider it together with its cash and equity.

MiMedx Total Assets Over Time

MiMedx Assets Financed by Debt

The debt-to-assets ratio shows the degree to which MiMedx uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

MiMedx Debt Ratio

10.0

It seems as most of the MiMedx's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the MiMedx's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of MiMedx, which in turn will lower the firm's financial flexibility.

MiMedx Corporate Bonds Issued

MiMedx Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how MiMedx prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MiMedx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MiMedx. By using and applying MiMedx Stock analysis, traders can create a robust methodology for identifying MiMedx entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MiMedx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MiMedx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

MiMedx Group stock analysis indicators help investors evaluate how MiMedx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MiMedx shares will generate the highest return on investment. By understating and applying MiMedx stock analysis, traders can identify MiMedx position entry and exit signals to maximize returns.

When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.